Quoin Pharmaceuticals Ltd. (QNRX) soared 192.32 percent, gaining $15.69 to $23.85 on Friday, after the company announced a securities purchase agreement with new healthcare focused institutional investors that could raise up to $104.5 million in gross proceeds. The deal includes an initial upfront funding of $16.5 million and up to an additional $88.0 million from potential warrant exercises. The stock is currently trading at $20.16, up sharply from the previous close of $8.16 on the Nasdaq. Shares opened at $12.21 and have traded between $11.71 and $41.80 today, with volume surging to 7.43 million shares, well above the average of 45,664. Over the past 52 weeks, Quoin Pharmaceuticals shares have ranged between $5.01 and $54.95.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.